John Butler
Directeur Général chez AKEBIA THERAPEUTICS, INC.
Fortune : 1 M $ au 30/06/2024
Profil
John P.
Butler is currently the President, Chief Executive Officer & Director at Akebia Therapeutics, Inc. He previously held positions as the Chief Executive Officer at Inspiration Biopharmaceuticals, Inc. in 2011, Chairman at American Kidney Fund, Inc. from 2013 to 2015, Chairman at Kidney Care Partners, Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2017, Independent Director at Zynerba Pharmaceuticals, Inc. from 2018 to 2023, Independent Director at Relypsa, Inc. from 2013 to 2016, and Product Manager at Amgen, Inc. from 1995 to 1997.
He also served as the SVP & President-Cardiometabolic & Renal at Genzyme Corp.
from 2009 to 2011 and as the Head-Sales & Marketing at Hoffmann-La Roche, Inc. Mr. Butler obtained an undergraduate degree from Manhattan College and an MBA from Baruch College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 1 467 810 ( 0,70% ) | 1 M $ | 30/06/2024 |
Postes actifs de John Butler
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Directeur Général | 16/09/2013 |
Anciens postes connus de John Butler
| Sociétés | Poste | Fin |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 10/10/2023 |
| KERYX BIOPHARMACEUTICALS | Président | 01/01/2017 |
| RELYPSA INC | Directeur/Membre du Conseil | 01/09/2016 |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Président | 01/01/2015 |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Directeur Général | - |
Formation de John Butler
| Baruch College | Masters Business Admin |
| Manhattan College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Health Services |
